news-med.jpg

Yumanity Therapeutics announces first clinical candidate for the potential treatment of Parkinson’s disease

First-in-Human Trials Planned for the Fourth Quarter of 2019 IND-Enabling Studies to Be Completed Utilizing Evotec INDiGO Platform

Topics: Corporate, IND Enabling, INDiGO, Evotec, Yumanity Therapeutics, Parkinson's disease Read More